These hub genes, particularly VPS35, VPS29, and GAK, hold potential not only as molecular drivers of Parkinson’s disease (Figure 5) but also as candidates for developing non-invasive urinary biomarkers for early diagnosis and therapeutic targeting. Here, VPS29 is linked to Parkinson disease.